Literature DB >> 1928175

Inactivation of Mycobacterium tuberculosis and Mycobacterium bovis by 14 hospital disinfectants.

W A Rutala1, E C Cole, N S Wannamaker, D J Weber.   

Abstract

Epidemics of mycobacteria due to contamination of medical devices continue to occur. For this reason, we assessed the ability of disinfectants, generally used in hospitals for disinfecting noncritical and semicritical patient care items, to inactivate mycobacteria. A modified Association of Official Analytical Chemists' (AOAC) Tuberculocidal Activity Test, using Middlebrook 7H9 broth as the primary subculture medium and neutralization by dilution, was used to assess the ability of 14 hospital disinfectants to inactivate about 10(6) Mycobacterium tuberculosis and about 10(5) Mycobacterium bovis at 20 degrees C using 10- or 20-minute exposure. All products were tested for each organism using 10 penicylinders (P) and were prepared at the manufacturers' recommended use-dilution. Chlorine dioxide, 0.80% hydrogen peroxide plus 0.06% peroxyacetic acid, and an iodophor achieved complete inactivation (0 + P) of both M. tuberculosis and M. bovis. One quaternary ammonium compound with a tuberculocidal label claim, a quaternary ammonium compound without a tuberculocidal label claim, chlorine (approximately 100 ppm) and 0.13% glutaraldehyde/0.44% phenol/0.08% phenate were not effective (10 + P) against both M. tuberculosis and M. bovis. Another quaternary ammonium compound with a tuberculocidal label claim was tested against only M. bovis and found ineffective (10 + P). Glutaraldehydes (2% alkaline and 2% acid), a phenolic and chlorine (approximately 1,000 ppm) demonstrated complete inactivation of M. tuberculosis (0 + P) and good inactivation of M. bovis (1-3 + P). Two disinfectants, hydrogen peroxide and ethyl alcohol, provided differing results against M. tuberculosis and M. bovis. These studies have important implications for disinfecting semicritical patient care items.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928175     DOI: 10.1016/0002-9343(91)90380-g

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Method for inactivating and fixing unstained smear preparations of mycobacterium tuberculosis for improved laboratory safety.

Authors:  Pamela Chedore; Cecelia Th'ng; Dennis H Nolan; George M Churchwell; David E Sieffert; Yvonne M Hale; Frances Jamieson
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Improved laboratory safety by decontamination of unstained sputum smears for acid-fast microscopy.

Authors:  Luiz Roberto Bigão Giacomelli; Cesar Helbel; Roger Leandro Nunes Ogassawara; Angela Maria Werneck Barreto; Fátima Moreira Martins; Celso Luíz Cardoso; Clarice Queico Fujimura Leite
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 4.  Uses of inorganic hypochlorite (bleach) in health-care facilities.

Authors:  W A Rutala; D J Weber
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

5.  Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room.

Authors:  Leslie Hall; Jonathan A Otter; John Chewins; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

6.  Rendering of mycobacteria safe for molecular diagnostic studies and development of a lysis method for strand displacement amplification and PCR.

Authors:  P Zwadyk; J A Down; N Myers; M S Dey
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

Review 7.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Viability testing of material derived from Mycobacterium tuberculosis prior to removal from a containment level-III laboratory as part of a Laboratory Risk Assessment Program.

Authors:  Kym S Blackwood; Tamara V Burdz; Christine Y Turenne; Meenu K Sharma; Amin M Kabani; Joyce N Wolfe
Journal:  BMC Infect Dis       Date:  2005-01-24       Impact factor: 3.090

9.  Optimization of a nanotechnology based antimicrobial platform for food safety applications using Engineered Water Nanostructures (EWNS).

Authors:  Georgios Pyrgiotakis; Pallavi Vedantam; Caroline Cirenza; James McDevitt; Mary Eleftheriadou; Stephen S Leonard; Philip Demokritou
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

10.  Disinfectant-susceptibility of multi-drug-resistant Mycobacterium tuberculosis isolated in Japan.

Authors:  Noriko Shinoda; Satoshi Mitarai; Eri Suzuki; Mineo Watanabe
Journal:  Antimicrob Resist Infect Control       Date:  2016-02-08       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.